期刊文献+

碘海醇脂质体的研制 被引量:3

Preparation of iohexol liposomes
下载PDF
导出
摘要 目的制备碘海醇脂质体并考察其体内外性质。方法采用逆相蒸发法制备碘海醇脂质体,用透射电镜观察脂质体的外观形态,激光散射测定Zeta电位和粒度分布,UV法测定脂质体的包封率,家兔体内实验验证造影效果。结果脂质体为封闭的多层囊状或多层圆球体,大小均匀。空白脂质体平均粒径166.2nm,多分散性指数0.461,Zeta电位-2.10mV;碘海醇脂质体平均粒径189.1nm,多分散性指数0.262,Zeta电位+3.40mV,碘海醇脂质体包封率81.92%;体内试验结果表明,脂质体包裹的造影剂比普通造影剂CT峰值推后,信号增强,作用时间延长。结论采用逆相蒸发法制备的碘海醇脂质体,包封率较高,体内应用可减少给药剂量、延长作用时间,并可能减小对血管和中枢神经的毒性。 OBJECTIVE: To study the preparation of iohexol liposomes and its properties in vivo and in vitro. METHODS: The liposomes were prepared by reverse-phase evaporation technique. The morphology of the liposomes was detected by transmission electron microscope. The Zeta potential and particle size distribution were evaluated by laser scatter. The entrapment efficiency was determined by UV. The opacification effect was authenticated by CT in rabbits. RESULTS: The lioosomes were in spherical or ellipsoidal shape, with multilayer and uniform size. The mean diameters of blank liposomes and iohexol liposomes were 166.2 nm and 189.1 nm, respectively. The polydispersity indexes were 0.461 and 0.262, respectively. The Zeta potentials were -2.10 mV and +3.40 mV, respectively. The entrapment efficiency of iohexol liposomes was 81.92%. In vivo study showed that, compared with iohexol injection, the CT peak value of liposomal iohexol was delayed. Iohexol liposomes had stronger signals and longer effective time than iohexol injection. CONCLUSION: The drug in the liposomes prepared by reverse-phase evaporation technique was highly entrapped into the liposomes. When used in vivo, iohexol liposomes may reduce the dosage, prolong the effective time and reduce the side effection on the blood vessels and the cerebral nerves.
出处 《中国药学杂志》 EI CAS CSCD 北大核心 2005年第12期916-918,共3页 Chinese Pharmaceutical Journal
关键词 碘海醇 脂质体 质量评价 Blood Drug dosage Drug products Evaporation Multilayers Neurology Transmission electron microscopy
  • 相关文献

参考文献6

二级参考文献9

  • 1薛玉英,翁帼英.阿糖腺苷脂质体含量及包封率测定[J].中国医药工业杂志,1993,24(4):160-164. 被引量:3
  • 2[1] Leenders ACAP, Marie SD. The use of lipid formulation of amphotericin B for systemic fungal infectious[J].Leukemia, 1996, 10:1570.
  • 3[2] Jill PA, Richard TP. Development, characterization, efficacy and mode of action of ambisome,a unilamellar liposomal formulation of amphotericin B[J].Journal of liposome Research,1993,3(3):429.
  • 4[3] Marie SD. Liposomal and lipid-based formulations of amphotericin B[J].Leukemia,1996,10(Suppl.2):S93.
  • 5Han Rui,Anticancer Drug Research and Experimental Technology,1997年,48页
  • 6Zhang Z H,Membrane Biophysics,1987年,28页
  • 7陈渊卿,蒋惠秋,张金德,严根宝,马积庆,沈德奋,顾健人.甘露醇—PVS对脂质体体外稳定作用的实验研究[J]药学学报,1982(11).
  • 8张俊红,朱家壁,王虹.阿米卡星脂质体的包封率测定[J].中国药学杂志,1999,34(12):818-820. 被引量:19
  • 9屠庆尧,钱树德,于德志.丁胺卡那霉素、卡那霉素、核糖霉素和妥布霉素等注射液的分光光度法测定[J].中国医药工业杂志,1992,23(8):365-366. 被引量:2

共引文献48

同被引文献45

  • 1刘杰,罗晓星,孟静茹,扈本荃,王海芳,孟嘉.脱氧核酶抑制耐甲氧西林金黄色葡萄球菌耐药基因的表达[J].中国临床药理学与治疗学,2004,9(6):641-645. 被引量:3
  • 2Fillion P,Desjardins A,Sayasith K,Lagace J.Encapsulation of DNA in negatively charged liposomes and inhibition of bacterial gene expression with fluid liposome-encapsulated antisense oligonucleotides[J].Biochim Biophys Acta,2001;1515:44-54
  • 3Zhang HZ,Hackbarth CJ,Chansky KM,Chmbers HF.A proteolytic transmembrane signaling pathway and resistant to betalactams in staphylococci[J].Science,2001;291:1962-5
  • 4Archer GL,Bosilevac JM.Signaling antibiotic resistant in staphylococci[J].Science,2001;291:1915-6
  • 5Sun LQ,Cairns MJ,Saravolac EG,Baker A,Gerlach WL.Catalytic Nucleic Acids:From Lab to Applications[J].Pharmcol Rev,2000;52:325-47
  • 6Carcia-Chaumont C,Seksek O,Grzybowska J.Delivery systems for antisense Oligonucleotides[J].Pharmacol Ther,2000;87:255-77
  • 7Desjardins A,Chen T,Khalil H,Sayasiyh K,Lagace J.Differential behavior of fluid liposomes toward Mammalian epithelial cells and bacteria:restriction of fusion to bacteria[J].J Drug Target,2002;10:47-54
  • 8Mugabe C,Azghani AO,Omri A.Liposome-mediated gentamicin delivery:development and activity against resistant of Pseudomonas aeruginosa isolated from cystic fibrosis patients[J].J Antimicro Chemother,2005;55,269-71
  • 9TOUITOU E,JUNGINGER H E,WEINER N D,et al.Liposomes as carriers for topical and transdermal delivery[J].J Pharm Sci,1994,83 (9):1189-1203.
  • 10PING Q N.Modern Pharmaceutics(现代药剂学)[M].Beijing:Chinese Medicine Science and Technology Publishing Press,1998:608.

引证文献3

二级引证文献39

相关作者

内容加载中请稍等...

相关机构

内容加载中请稍等...

相关主题

内容加载中请稍等...

浏览历史

内容加载中请稍等...
;
使用帮助 返回顶部